Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Regen Biopharma Inc (RGBP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 100 K
  • Annual Income, $ -7,751 K
  • 36-Month Beta N/A
  • Price/Sales 58.01
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0030 +23.33%
on 12/14/18
0.0095 -61.05%
on 12/07/18
-0.0009 (-19.57%)
since 11/16/18
3-Month
0.0030 +23.33%
on 12/14/18
0.0250 -85.20%
on 09/21/18
-0.0128 (-77.58%)
since 09/18/18
52-Week
0.0030 +23.33%
on 12/14/18
0.0700 -94.71%
on 02/09/18
-0.0535 (-93.53%)
since 12/18/17

Most Recent Stories

More News
Regen BioPharma, Inc. Reports Additional New NR2F6 Small Molecule Inhibitors

Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) researchers have identified three new series of small molecule drugs that inhibit NR2F6, bringing the total number of these series to five.

RGBP : 0.0037 (+15.63%)
RGBPP : 0.0063 (+18.87%)
Increasing Number of Cancer Cases to Fuel the Global Cancer Immunotherapy Market Growth

According to data compiled by Transparency Market Research, the global cancer immunotherapy market is expected to grow from USD 37.50 Billion in 2015 to USD 124.88 Billion by 2024 while registering a CAGR...

RGBP : 0.0037 (+15.63%)
CRIS : 0.78 (-4.88%)
BPTH : 0.21 (-12.50%)
ATHX : 1.69 (-1.74%)
BLRX : 0.55 (-9.84%)
Regen BioPharma, Inc. Determines Its Lead NR2F6 Agonist Ready for Inflammatory Bowel Disease Animal Studies

Regen BioPharma, Inc. (OTCQB: RGBP) and (OTCQB: RGBPP), reports its researchers have determined that its lead NR2F6 small molecule agonist, RG-NAH005, is now ready for testing in animal models of inflammatory...

RGBP : 0.0037 (+15.63%)
RGBPP : 0.0063 (+18.87%)
Regen BioPharma, Inc. Reports Activation of Immune Cells by Its NR2F6 Small Molecule Inhibitors

Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP), reports its researchers have identified a series of small molecule drugs that inhibit NR2F6 and also activate human immune cells ex-vivo. Evidence...

RGBP : 0.0037 (+15.63%)
RGBPP : 0.0063 (+18.87%)
Regen BioPharma, Inc. Reports Activation of Immune Cells by Its NR2F6 Small Molecule Inhibitors

SAN DIEGO , September 21, 2018 /PRNewswire/ --

RGBP : 0.0037 (+15.63%)
RGBPP : 0.0063 (+18.87%)
Immunotherapy Market Value Grows as the Treatments Gains Widespread Importance

According to a report published by Progressive Markets, the cancer immunotherapy market was valued at USD 57.2 Billion in 2017 and is expected to reach USD 166.7 Billion by 2025 while growing at a compound...

AGEN : 2.08 (-5.88%)
RGBP : 0.0037 (+15.63%)
ZIOP : 2.41 (-9.40%)
PTN : 0.71 (+1.43%)
BLRX : 0.55 (-9.84%)
Regen BioPharma, Inc. Updates Report on Success of Its NR2F6 Small Molecule Antagonist Screening Program for Treating Cancer

SAN DIEGO , September 11, 2018 /PRNewswire/ --

RGBP : 0.0037 (+15.63%)
RGBPP : 0.0063 (+18.87%)
Global Biotechnology Market Grows as Demand for Immunotherapy Cancer Treatment Increases

Data compiled by Grand View Research indicates that the global biotechnology market is expected to reach USD 727.1 Billion by 2025. The technological advancement of regenerative therapies is one of the...

RGBP : 0.0037 (+15.63%)
ADMP : 2.46 (-5.38%)
NVAX : 2.12 (-6.61%)
PTN : 0.71 (+1.43%)
SGYP : 0.11 (-8.33%)
Regen BioPharma, Inc. Files New Composition of Matter Patent Application Based on Its Successful Modulation of NR2F6 by Its Small Molecule Compounds

Regen BioPharma, Inc. (OTCQB: RGBP) and (OTCQB: RGBPP) has filed a patent application covering composition of matter and methods of use related to molecules identified in its small molecule program that...

RGBP : 0.0037 (+15.63%)
RGBPP : 0.0063 (+18.87%)
Entest Group, Inc. Declares Property Dividend of 3,000,000 Common Shares of Zander Therapeutics Inc.

On May 10, 2018, Entest Group, Inc. (OTC: ETNI) declared the distribution on a pro rata basis as a dividend in kind of 3,000,000 of the common shares of Zander Therapeutics, Inc., par value $0.0001, currently...

RGBP : 0.0037 (+15.63%)
RGBPP : 0.0063 (+18.87%)
ETNI : 0.0189 (-0.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade RGBP with:

Key Turning Points

2nd Resistance Point 0.0050
1st Resistance Point 0.0041
Last Price 0.0037
1st Support Level 0.0027
2nd Support Level 0.0022

See More

52-Week High 0.0700
Fibonacci 61.8% 0.0444
Fibonacci 50% 0.0365
Fibonacci 38.2% 0.0286
Last Price 0.0037
52-Week Low 0.0030

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar